Stent type and interrupted anti-platelet therapy does not correlate with adverse events after non-cardiac surgeries

Guidelines recommend delaying elective surgery in patients with drug eluting stent for one year after stent implantation to allow completion of 1 year of dual anti-platelet therapy without interruption. This recommendation is based on expert consensus and results in several clinical questions, including whether it is preferable to use a bare metal stent in patients with a potential for future surgery and whether this delay is excessive for patients considering surgery with other potential benefits (ie, knee replacement in patients with life-limiting osteoarthritis). Accordingly, the authors sought to understand the risk of major adverse cardiovascular events (MACE) following non-cardiac surgery among patients with coronary stents as a function of time since coronary stenting, stent type, and antiplatelet therapy …